Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention
- 1 January 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (1) , 178-185
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH) (2 P50 CA089019)
- Komen Foundation (BCTR 20000690)
This publication has 27 references indexed in Scilit:
- Effects on Gene Expression in Rat Liver after Administration of RXR Agonists: UAB30, 4-Methyl-UAB30, and Targretin (Bexarotene)Molecular Pharmacology, 2013
- Methyl Effects on Protein–Ligand BindingJournal of Medicinal Chemistry, 2012
- Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studiesDrug and Chemical Toxicology, 2011
- A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersCancer Prevention Research, 2010
- Structure, Energetics, and Dynamics of Binding Coactivator Peptide to the Human Retinoid X Receptor α Ligand Binding Domain Complex with 9-cis-Retinoic AcidBiochemistry, 2010
- Conformationally Defined Retinoic Acid Analogues. 5. Large-Scale Synthesis and Mammary Cancer Chemopreventive Activity for (2E,4E,6Z,8E)-8- (3‘,4‘-Dihydro-1‘(2‘H)-naphthalen-1‘-ylidene)-3,7-dimethyl-2,4,6-octatrienoic Acid (9cUAB30)Journal of Medicinal Chemistry, 2003
- Conformationally Defined Retinoic Acid Analogues. 4. Potential New Agents for Acute Promyelocytic and Juvenile Myelomonocytic LeukemiasJournal of Medicinal Chemistry, 1998
- Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective RetinoidsJournal of Medicinal Chemistry, 1994
- Retinoids Selective for Retinoid X Receptor Response PathwaysScience, 1992
- Methanesulfonic acid catalyzed cyclization of 3-arylpropanoic and 4-arylbutanoic acids to 1-indanones and 1-tetralonesThe Journal of Organic Chemistry, 1981